-+ 0.00%
-+ 0.00%
-+ 0.00%

Maximus (MMS) Stock Looks Below Fair Value While Earnings Face Budget Risk

Simply Wall St·07/15/2026 21:35:58
Listen to the news

Maximus stock has had a difficult year so far, with the share price down about 33.0% year to date, even as valuation checks suggest the current price may be on the cheap side for a government services contractor with steady contract exposure.

  • Year to date, Maximus shares have declined 33.0%, which means investors are reassessing what they are willing to pay for the company after several years of weaker share performance.
  • Growing attention on the company’s government contract work and operational efficiency can support sentiment on earnings and cash flow, while heavy reliance on federal and state spending leaves the valuation exposed to changes in public budgets and regulation.
  • On Simply Wall St’s broader checks, Maximus screens as undervalued in 5 out of 6 areas, which indicates the stock looks cheap on several fundamental measures rather than expensive or fully priced; see the value score of 5 for the full breakdown.

The stock’s next move may depend on whether this weaker share performance already reflects the key risks to Maximus, or whether the current valuation still leaves a margin of safety for long term holders.

Maximus delivered -17.1% returns over the last year. See how this stacks up to the rest of the Professional Services industry.

Is Maximus Still Cheap on Earnings?

The P/E multiple fits Maximus well because earnings are a key way investors tend to look at established government services contractors. Maximus currently trades on about 8.2x earnings, compared with a Professional Services industry average of roughly 19.9x and a peer group average near 12.8x, so the stock sits at a clear discount to both benchmarks.

On Simply Wall St’s fair P/E estimate of 16.1x, which reflects the company’s profile, Maximus changes hands at roughly half the multiple this model would expect. Despite recent investor attention on government contract growth and operational efficiency, the current P/E still prices Maximus below where this framework suggests a typical market valuation might sit for the stock.

On the P/E multiple alone, Maximus appears undervalued compared with both peers and its modelled fair ratio.

NYSE:MMS P/E Ratio as at Jul 2026
NYSE:MMS P/E Ratio as at Jul 2026

See what the numbers say about this price — find out in our valuation breakdown.

The Maximus Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Maximus bridge the gap between the current P/E discount and what would need to be true about Maximus' future growth, margins and earnings for the stock to be worth materially more or less than today’s price. These Narratives are available on the company’s Community page. Each Narrative sets out a fair value as a thesis about how the business could perform, so you can track over time whether that view still holds up.

One of the top community narratives on Maximus: 45% undervalued

"Pending implementation of new federal legislation (e.g. Medicaid work requirements, increased eligibility reviews, and SNAP payment integrity) is set to significantly expand state demand for Maximus' compliance and administration services starting in FY27..."

Read one of the top narratives on Maximus

Do you think there's more to the story for Maximus? Head over to our Community to see what others are saying!

The Bottom Line

For Maximus, the key point is that the stock still screens as undervalued on earnings multiples, even after a difficult year to date. The current discount to both the industry and peer P/E benchmarks suggests the market is pricing in meaningful concern about contract risk and public budget exposure. Whether that gap closes or persists will likely come down to one question: whether Maximus can sustain earnings quality and operational discipline in the face of changing federal and state spending priorities, rather than just headline contract wins.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.